Yi Li

机构：Qingdao University, Fujian University of Traditional Chinese Medicine, Union Hospital, Fudan University, Minhang District Central Hospital, Hubei Provincial Center for Disease Control and Prevention, Fujian Academy of Building Research (China), Precision for Medicine (United States), Affiliated Hospital of Qingdao University, State Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing, The First People's Hospital of Jiangxia District, Huazhong University of Science and Technology · ORCID：0000-0003-0398-0967

发表论文 181 篇 · 总被引 4882 次 · h-index 39

代表论文

• Polyphenol-stabilized coacervates for enzyme-triggered drug delivery (2024 · Nature Communications · 被引 49)
• Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (2024 · Med · 被引 41)
• Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy (2024 · ACS Applied Materials & Interfaces · 被引 23)
• Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline (2024 · Nature Communications · 被引 22)
• Self-Assembled Homopolymeric Spherulites from Small Molecules in Solution (2023 · Journal of the American Chemical Society · 被引 21)
• Nitrogen-doped carbon decorated with metal carbide and metal in Li-S chemistry up to 3500 cycles (2024 · Chemical Engineering Journal · 被引 19)